May 13, 2021 01:41 PM EDTUpdated 02:15 PM

Vaccine maker Northwest Bio claims it's in the homestretch for its manufacturing expansion in the UK

Josh Sullivan

While the last 2 years have been a roller coaster for Maryland-based vaccine maker Northwest Biotherapeutics — highlighted by a $250,000 fine from the SEC, years …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Vaccine maker Northwest Bio claims it's in the homestretch for its manufacturing expansion in the UK

Josh Sullivan

Sign up to read this article for free.

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

Secretive Treeline Biosciences discloses $421M financing in filing

House’s prominent China critic Jim McGovern leads opposition to Biosecure Act: ‘I would prefer to go back to the ...

BenevolentAI CEO is out after less than a year on the job

FDA approves AbbVie's 24-hour Parkinson's infusion therapy after two CRLs

Sage shakes up senior management, slashes pipeline, sheds 33% of staff

Join the GenScript Biotech Global Forum: Unlocking Innovations in Cell and Gene Therapies

Vac­cine mak­er North­west Bio claims it's in the home­stretch for its man­u­fac­tur­ing ex­pan­sion in the UK

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Vaccine maker Northwest Bio claims it's in the homestretch for its manufacturing expansion in the UK